Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/16452
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTerris-Prestholt, Fernen
dc.contributor.authorHanson, Karaen
dc.contributor.authorMacPhail, Catherineen
dc.contributor.authorVickerman, Peteren
dc.contributor.authorRees, Helenen
dc.contributor.authorWatts, Charlotteen
dc.date.accessioned2015-01-12T17:32:00Z-
dc.date.issued2013-
dc.identifier.citationPLoS One, 8(12), p. 1-13en
dc.identifier.issn1932-6203en
dc.identifier.urihttps://hdl.handle.net/1959.11/16452-
dc.description.abstractBackground: For the first time in the history of HIV, new bio-medical interventions have been shown to be effective in preventing HIV transmission. For these new HIV prevention technologies (NPTs) to have an impact on the epidemic, they must be widely used. This study uses a discrete choice experiment (DCE) to: understand the relative strength of women's preferences for product characteristics, understand the implications for substitution away from male condoms, and inform realistic modelling of their potential impact and cost-effectiveness. Methods: A DCE was conducted among 1017 women in urban South Africa. Women were presented with choices between potential women's NPTs (microbicides, diaphragm, female condom) and 'what I did last time' (use or not use a condom) with different HIV and pregnancy prevention effectiveness' and prices. Choice probabilities are estimated using the nested logit model and used to predict uptake. Results: In this high HIV prevalence setting, HIV prevention effectiveness is the main driver of uptake followed by pregnancy prevention effectiveness. For example a microbicide with poor effectiveness would have niche appeal at just 11% predicted uptake, while a highly effective microbicide (95% effective against HIV and pregnancy) would have far wider appeal (56% predicted uptake). Though women who reported not using condoms were more likely to choose the NPTs, at current very high rates of male condom use in South Africa (60%), about half of microbicide uptake is projected to be among those currently not using condoms. Conclusions: Women are very interested in NPTs, especially if highly effective in preventing HIV and pregnancy. Women in greatest need were also most likely to switch to the new products. Where products are not yet available for distribution, proxy data, such as that generated by DCEs, can bring realism to overly optimistic uptake scenarios found in many current impact models.en
dc.languageenen
dc.publisherPublic Library of Scienceen
dc.relation.ispartofPLoS Oneen
dc.titleHow Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africaen
dc.typeJournal Articleen
dc.identifier.doi10.1371/journal.pone.0083193en
dcterms.accessRightsGolden
dc.subject.keywordsPreventive Medicineen
dc.subject.keywordsHealth Economicsen
dc.subject.keywordsHealth Promotionen
local.contributor.firstnameFernen
local.contributor.firstnameKaraen
local.contributor.firstnameCatherineen
local.contributor.firstnamePeteren
local.contributor.firstnameHelenen
local.contributor.firstnameCharlotteen
local.subject.for2008111712 Health Promotionen
local.subject.for2008140208 Health Economicsen
local.subject.for2008111716 Preventive Medicineen
local.subject.seo2008910209 Preference, Behaviour and Welfareen
local.subject.seo2008920401 Behaviour and Healthen
local.profile.schoolSchool of Rural Medicineen
local.profile.emailcmacphai@une.edu.auen
local.output.categoryC1en
local.record.placeauen
local.record.institutionUniversity of New Englanden
local.identifier.epublicationsrecordune-20150112-170450en
local.publisher.placeUnited States of Americaen
local.identifier.runningnumbere83193en
local.format.startpage1en
local.format.endpage13en
local.peerreviewedYesen
local.identifier.volume8en
local.identifier.issue12en
local.access.fulltextYesen
local.contributor.lastnameTerris-Prestholten
local.contributor.lastnameHansonen
local.contributor.lastnameMacPhailen
local.contributor.lastnameVickermanen
local.contributor.lastnameReesen
local.contributor.lastnameWattsen
dc.identifier.staffune-id:cmacphaien
local.profile.orcid0000-0002-0614-0157en
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.identifier.unepublicationidune:16689en
local.identifier.handlehttps://hdl.handle.net/1959.11/16452en
dc.identifier.academiclevelAcademicen
local.title.maintitleHow Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africaen
local.output.categorydescriptionC1 Refereed Article in a Scholarly Journalen
local.search.authorTerris-Prestholt, Fernen
local.search.authorHanson, Karaen
local.search.authorMacPhail, Catherineen
local.search.authorVickerman, Peteren
local.search.authorRees, Helenen
local.search.authorWatts, Charlotteen
local.uneassociationUnknownen
local.identifier.wosid000329194700028en
local.year.published2013en
local.subject.for2020420603 Health promotionen
local.subject.for2020380108 Health economicsen
local.subject.for2020420317 Patient safetyen
local.subject.seo2020150509 Preference, behaviour and welfareen
local.subject.seo2020200401 Behaviour and healthen
Appears in Collections:Journal Article
School of Rural Medicine
Files in This Item:
2 files
File Description SizeFormat 
Show simple item record

SCOPUSTM   
Citations

51
checked on Jul 6, 2024

Page view(s)

2,260
checked on Jul 7, 2024
Google Media

Google ScholarTM

Check

Altmetric


Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.